Thursday, March 23, 2023
8:00 PM to 9:00 PM ET
7:00 PM to 8:00 PM CT
5:00 PM to 6:00 PM PT
Live, virtual activity
Target Audience
This CE activity is intended for oncology nurses, PAs, and other healthcare professionals involved in the care of patients with blood cancer.
Learning Objectives
After completing this CE activity, the participant should be better able to:
-
Describe the goals and types of hematopoietic cell transplantation used in the treatment of blood cancers, including autologous, allogeneic, and reduced-intensity allogeneic stem-cell transplantation
-
Describe the indications for hematopoietic stem cell transplant
-
Explain the process of pre-transplant evaluation, mobilization, cell collection, and cell infusion in patients with blood cancer
-
Explain the short and long-term follow up requirements
-
Identify resources for patient education and support
Speakers
Krishna Komanduri, MD
Julius R. Krevans Distinguished Professor of Medicine
Chief, UCSF Health Division of Hematology/Oncology
Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
Corinne Shamehdi, MPAS, PA-C
Inpatient Lead APP
Hematology/Oncology
Tampa General Hospital Cancer Institute
Tampa, FL
This activity is provided by The Leukemia & Lymphoma Society, in collaboration with The AAPA African Heritage PA Caucus.
There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.
